Goodvastatin 10 contains Atorvastatin 10 mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Goodvastatin 10 acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, thereby decreasing cholesterol production in the liver and enhancing the clearance of LDL particles from the bloodstream. This mechanism contributes to the prevention of atherosclerosis and reduces the risk of cardiovascular events such as myocardial infarction, stroke, and angina in patients with established coronary heart disease or those at high risk. The recommended dosage is individualized based on patient response and lipid levels, with regular monitoring of liver function tests and lipid profiles advised during therapy. Goodvastatin 10 is contraindicated in patients with active liver disease, pregnancy, or breastfeeding. Common adverse effects may include headache, myalgia, and gastrointestinal disturbances. Patients should be counseled on adherence, lifestyle modification, and the importance of reporting any unexplained muscle pain or weakness promptly.